From: Comorbidities and outcomes among patients hospitalized with COVID-19 in Upper Egypt
Number need MV* (MV/total cases) | % from comorbidity | % from MV (n = 102) | |
---|---|---|---|
Comorbidity | |||
Diabetes mellitus | 48/147 | 32.7 | 47.1 |
Hypertension | 58/172 | 33.7 | 56.9 |
Cardiac diseases | 20/56 | 35.7 | 19.6 |
Chronic pulmonary diseases | 9/31 | 29.0 | 8.8 |
Neuropsychiatric diseases | 10/31 | 32.3 | 9.8 |
Kidney disease | 9/21 | 42.9 | 8.8 |
Liver disease | 3/15 | 20.0 | 2.9 |
Metabolic and endocrinal diseases | 3/10 | 30.0 | 2.9 |
Autoimmune diseases | 2/7 | 28.6 | 2.0 |
Malignancy | 1/3 | 33.3 | 0.98 |
Number of comorbidities | |||
No comorbidity | 18/168 | 10.7 | 17.6 |
One comorbidity | 31/121 | 25.6 | 30.4 |
Two comorbidities | 31/92 | 33.7 | 30.4 |
Three comorbidities | 19/49 | 38.8 | 18.6 |
Four comorbidities | 3/9 | 33.3 | 2.9 |